REG - ABCAM Plc - Notification of Interim Results

 
For best results when printing this announcement, please click on the link below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100209:nRSI8514Ga
RNS Number : 8514G
ABCAM Plc
09 February 2010 
 
 For immediate release  9 February 2010  
 
 
9 February 2010 
 
ABCAM PLC 
 
("Abcam" or "the Company") 
 
Notification of Interim Results 
 
Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, will
announce its interim results for the six months ended 31 December 2009 on Tuesday 9 March 2010. 
 
An analyst meeting will be held at 10:00am on Tuesday 9 March at the offices of Buchanan Communications, 45 Moorfields,
London EC2Y 9AE. 
 
For further information please contact: 
 
Abcam                                                                           + 44 (0) 1223 696000 
 
Jonathan Milner, Chief Executive Officer 
 
Jeff Iliffe, Chief Financial Officer 
 
www.abcam.com 
 
Numis Securities                                                           + 44 (0) 20 7260 1000 
 
Michael Meade / Nick Westlake - Nominated Adviser 
 
James Black - Corporate Broking 
 
Buchanan Communications                                          + 44 (0) 20 7466 5000 
 
Mark Court / Stasa Filiplic 
 
This information is provided by RNS
The company news service from the London Stock Exchange 
 


back to RNS news

©1998-2010 Abcam plc. All rights reserved. Abcam plc is incorporated in the UK, its main country of operations is the UK.
Share price and news information on this site is updated dynamically from external data feeds. Static content was last updated on 9 August 2010